Opzelura® 15 mg/g cream (ruxolitinib phosphate): Important information regarding presence of particles in Opzelura cream
10/06/2025
Medicines for human use
Direct healthcare professional communication (DHPC)
Important Safety Information from Incyte Biosciences Distribution B.V. (“Incyte”), regarding Opzelura® 15 mg/g cream (ruxolitinib phosphate) dated 05 June 2025: Important information regarding presence of particles in Opzelura cream